Regenerative Medicine as a Disrupter in Clinical Trials
PharmaTalkRadio30 Heinä 2019

Regenerative Medicine as a Disrupter in Clinical Trials

This is a keynote session from DPharm 2018. Dr Atala, a renowned key opinion leader on the topic of regenerative medicine, brings the DPharm audience a fascinating presentation on how it's possible to reduce the number of patients needed in clinical trials with the advancement of regenerative medicine, and how regenerative medicine can improve accuracy and speed up the clinical trial process. Speaker: Anthony Atala, MD, Director, Wake Forest Institute for Regenerative Medicine The 9th annual DPharm conference will take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(461)

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-hereilla
rss-poliisin-mieli
rss-duodecim-lehti
rss-totuuden-liepeilla
rss-radplus
utelias-mieli
docemilia
rss-tiedetta-vai-tarinaa
rss-kasvikutsut
university-of-eastern-finland
tiedekulma-podcast
sotataidon-ytimessa
radio-antro
filocast-filosofian-perusteet
rss-bios-podcast
rss-laakaripodi
rss-ilmasto-kriisissa
rss-ylistys-elaimille
rss-lihavuudesta-podcast